2006
DOI: 10.1007/s00280-006-0227-4
|View full text |Cite
|
Sign up to set email alerts
|

Cyclopamine increases the cytotoxic effects of paclitaxel and radiation but not cisplatin and gemcitabine in Hedgehog expressing pancreatic cancer cells

Abstract: These data suggest strategies to combine Hh inhibitors with radiotherapy and chemotherapeutic agents, specifically paclitaxel and related compounds in the treatment of pancreatic cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
37
0

Year Published

2007
2007
2014
2014

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 47 publications
(43 citation statements)
references
References 18 publications
5
37
0
Order By: Relevance
“…The same effect was found in human pancreatic cancer cells PANC-1, SUIT-2, and AsPC-1, when cyclopamine and EGFR inhibitor were combined [54]. Furthermore, cyclopamine was shown to increase the cytotoxic effects of paclitaxel and radiation therapy in human pancreatic cancer cells MiaPaCa-2, BxPC-3, and HCT116 [55]. Unpublished data from our research group also suggest that treatment of different pancreatic cancer cell lines with cyclopamine (alone or in combination with 5-FU) reduces the amount of SP cells and, most interestingly, restores the acquired 5-Fluorouracil-induced chemoresistance in AsPC-1 and L3.6pl pancreatic cancer cell lines in vitro.…”
Section: Targeting Pancreatic Cancer Cells With Stem-like Characterissupporting
confidence: 63%
“…The same effect was found in human pancreatic cancer cells PANC-1, SUIT-2, and AsPC-1, when cyclopamine and EGFR inhibitor were combined [54]. Furthermore, cyclopamine was shown to increase the cytotoxic effects of paclitaxel and radiation therapy in human pancreatic cancer cells MiaPaCa-2, BxPC-3, and HCT116 [55]. Unpublished data from our research group also suggest that treatment of different pancreatic cancer cell lines with cyclopamine (alone or in combination with 5-FU) reduces the amount of SP cells and, most interestingly, restores the acquired 5-Fluorouracil-induced chemoresistance in AsPC-1 and L3.6pl pancreatic cancer cell lines in vitro.…”
Section: Targeting Pancreatic Cancer Cells With Stem-like Characterissupporting
confidence: 63%
“…A recent study through transgenic mouse model indicated that the cooperation of Hh and Ras signaling was crucial during the earliest stages of PDA formation [15], and the overexpression of Shh in pancreatic cancer stem cells (CSCs) showed that Hh signaling might play a role in the regulation of self-renewal and resistance to chemoradiation in pancreatic CSCs [16]. Furthermore, the therapeutic effects through the blockade of Hh pathway support that Hh signaling represents possible target of new treatment strategies for pancreatic cancer [17][18][19]. However, in a latest study, Nolan-Stevaux and his colleagues reported that autocrine Shh-Ptch-Smo signaling was not required in pancreatic ductal cells for PDAC progression, since the deletion of Smo in the pancreas failed to affect the multistage development of PDAC tumors.…”
Section: Discussionmentioning
confidence: 93%
“…Cytokines are indispensable markers for classification of poorly differentiated or phenotypically ''deviant'' tumors. Cytokines 8,18, and 19 are prevalent in squamous cell carcinoma, and specific antibodies against them aid in diagnosing NPC. To determine whether there were expression differences in the three cytokines between SP and NSP cells, freshly sorted cells were grown on sterile glass cover slides overnight at 37jC, washed twice with PBS, and fixed in 4% paraformaldehyde for 30 min at 4jC.…”
Section: Methodsmentioning
confidence: 99%